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Dextran sodium sulfate (DSS) is a widely used chemical 
model for inflammatory bowel disease (IBD). It is thought 
that imbalances in the T helper (Th) cell subsets contribute to 
IBD. Recent studies suggest that the acute DSS-colitis mod-
el is polarized toward a Th1/Th17 profile based on RT-PCR 
analysis of colonic tissues. In the current study we de-
termined whether colonic Th cells from DSS-colitis mice 
were skewed toward the Th17 profile. Mice were treated 
with 5% DSS for 7 days and colonic T cells isolated and ex-
amined for production of IFN-γ  (Th1 cell), IL-4 (Th2 cell) and 
IL-17 (Th17 cell) by intracellular flow cytometry. We found 
that the percentage of colonic Th17 cells were similar to 
non-treated controls but the percentage of Th1 cells were 
elevated in DSS-colitis mice. These results suggest that in 
the acute DSS-colitis model the colonic Th cells exhibit a Th1 
profile and not a Th17 profile.
[Immune Network 2011;11(6):416-419]
Inflammatory bowel disease (IBD) is defined as a chronic in-
flammatory disorder of the gastrointestinal tract and is classi-
fied as Crohn’s disease or ulcerative colitis based on distinct 
c l i n i c a l ,  e n d o s c o p i c  a n d  h i s t o p a t h o l o g i c a l  f e a t u r e s .  M u l t i p l e  
studies suggest that microbial, environmental and genetic fac-
tors contribute to the pathogenesis of this disorder [reviewed 
in  (1,2)].  These  factors  ultimately  culminate  in  an  inap-
propriate adaptive  immune response  which perpetuates  the 
chronic intestinal inflammation. Much of our mechanistic un-
derstanding of IBD pathogenesis has been extrapolated from 
studies of animal models (3). Among these animal model sys-
tems, the oral uptake of dextran sodium sulfate (DSS) by mice 
induces a phenotype similar to ulcerative colitis and is widely 
used  by  researchers  to  study  IBD  (4).
    DSS damages the colonic epithelial barrier which then ex-
posures  the  underlying  tissues  to  bacterial  flora  and  results 
in  subsequent  inflammation  and  induction  of  Th  cell  res-
ponses. The murine DSS-induced colitis model recapitulates 
many aspects of human IBD such as cytokine dysregulation 
which is a key feature of IBD pathogenesis (5). This dysregu-
lation is thought to be due to the imbalance of T helper (Th) 
cell subsets such as T helper 1 (Th1) and T helper 2 (Th2) 
cells. Crohn’s disease is characterized by a Th1 cytokine pro-
file mediated by the cytokines IFN-γ, IL-12 and TNF-α. In 
contrast, ulcerative colitis is characterized by a Th2 cytokine 
profile  mediated  by  the  cytokines  IL-4  and  IL-5.  However, 
this  simplified  classification  has  been  challenged  by  studies 
suggesting that Crohn’s disease is characterized by the pro-
duction of IL-17 (6,7). In an acute model of DSS-colitis, Alex 
et al. showed that mice give DSS for 7 days exhibited an in-
crease  in  IL-12  and  IL-17  suggesting  an  induction  of  a 
Th1/Th17  profile  (7).  However, i n  t h i s  s t u d y  p r o t e i n  a n d  
mRNA samples from whole colonic tissues and serum were 
analyzed and not Th cells. Therefore, it is unclear if indeed 
the Th cells were also polarized toward the Th1/ Th17 subset. 
In  this  current  report,  we  examined  the  percentages  of 
Th1/Th2/Th17 cells in the colonic tissues of DSS-treated mice 
to determine whether the Th cells were polarized to the Th1 
and/or  Th17  subset.
    Six-week-old  female  C57Bl/6  mice  (ORIENT  BIO,  Korea) T Helper Cell Responses in DSS Colitis Model
Yoon Suk Kim, et al.
417 IMMUNE NETWORK http://www.ksimm.or.kr Volume 11 Number 6 December 2011
Figure 1. H&E staining of colons from control mice and DSS-treated
mice. Mice were administered 5% DSS in the drinking water for 7
days.
Figure 2. Intracellular cytokine flow cytometric analysis of colonic 
CD3
＋4
＋ T cells from the large intestines of DSS-treated mice and 
control mice. After one week of DSS treatment, isolated lymphocytes
were treated with PMA, ionomycin, GolgiPlug
TM for 4 hours and 
stained with antibodies against cell surface markers and cytokines. Dot 
plots were derived from cells gated on the CD3
＋4
＋ T cell population.
Data are representative of three independent experiments. The num-
bers inside each quadrant indicate the percentage of the cell po-
pulation. were given 5% (w/v) DSS (MW 30,000∼45,000, MP Bioche-
micals,  Solon,  OH,  USA)  in  the  drinking  water  and  fed  ad 
libitum for 7 days. Control mice received water without DSS. 
This study was approved by the Institutional Review Board 
of Yonsei University at Wonju, South Korea. We isolated the 
colonic lymphocytes and conducted intracellular staining by 
flow cytometry as previously described (8). In brief, pooled 
large intestines (3 mice per group) were minced and enzy-
matically digested with Liberase
TM (Roche, USA) and DNase 
I (Roche). The lymphocytes were isolated by using a Percoll 
gradient. Cells were stimulated for 4 hr in vitro in the pres-
ence  of  PMA  (30  nM)  (Promega,  USA),  ionomycin  (1μM) 
(Sigma, USA) and GolgiPlug
TM (BD Biosciences, USA). Then 
t h e  c e l l s  w e r e  w a s h e d ,  f i x e d  a n d  s t a i n e d  f o r  c e l l  s u r f a c e  
markers and intracellular cytokines. Cells were analyzed us-
ing  FACSCalibur  (BD  Biosciences).
  Mice administered DSS developed fulminant colitis as de-
termined by hematoxylin and eosin (H&E) staining of the co-
lon (Fig. 1). In addition, the DSS-treated mice exhibited rectal 
bleeding, decrease in body weight and shortening of the co-
lon length which are all characteristic features of DSS-colitis 
(data  not  shown)  (4).  We  analyzed  the  Th  cell  population 
(i.e., CD3
＋4
＋ T cells) for production of the intracellular cyto-
kines IFN-γ, IL-4 and IL-17 and found that compared to the 
control mice Th cells from the DSS-treated mice did not show 
an  increase  in  IL-17  producing  CD3
＋4
＋ T  c e l l s  ( D S S  6 . 8 % 
versus  control  8.3%)  (Fig.  2).  Similarly,  the  percentages  of 
IL-4  producing  CD3
＋4
＋  T  cells  were  comparable  in  both 
groups of mice (DSS 2.2% versus control 2.6%). In contrast, 
the percentages of IFN-γ producing CD3
＋4
＋ T cells were 
increased two-fold in the DSS-treated group compared to the 
control group (DSS 12.1% versus control 5.6%). These results 
indicate that in the acute DSS-colitis model the Th cells ex-
hibit  a  predominantly  Th1  profile.
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cent  studies  that  were  published  during  the  preparation  of 
this manuscript (9-12). The results from these studies suggest 
that the DSS colitis model is Th1/Th17 polarizing. The afore-
mentioned  studies  differ  from  our  study  in  that  the  mouse 
strains  used,  DSS  dose  and  DSS  administration  times  are 
different. Studies have demonstrated that the DSS dose affects 
t he  e x te n t o f c o lo ni c i nf lam m at io n w h ic h m ay  al so  le ad  to 
different  Th  differentiation  programs  (13).  The  results  from 
this current study indicate that in the acute DSS-colitis model 
the  Th  cell  cytokine  profile  is  strictly  Th1  polarizing. 
Therefore, we suggest that the IL-17 production in the DSS 
model  is  due  to  other  cell  types.  Several  studies  have  in-
dicated IL-17 can be produced by CD8
＋ T cells (14), NKT 
cells (15,16), neutrophils (17) and paneth cells (18). Recent 
studies have shown that the colonic lamina propria γ/δ T 
cells can also be a source of IL-17 producing cells (8,19). We 
did not find an increase in CD3
＋4
− IL-17 producing cells in 
the DSS treated  mice  suggesting that  γ/δ T cells are not 
a major contributor of IL-17 in this model (data not shown).
  I n  C r o h n ’s disease, the cytokine makeup is considered to 
be skewed toward the Th1/Th17 profile whereas in ulcerative 
colitis  Th2  profile  dominates.  Therefore,  our  data  suggests 
that although the murine DSS model histopathologically mim-
ics ulcerative colitis the Th response is not Th2. Additionally, 
the Th1/Th17 response observed in human Crohn’s disease 
was also not mirrored in the murine DSS-colitis model. The 
results from this current study raise a cautionary note when 
extrapolating results from murine DSS studies to human IBD.
    Our  flow  cytometric  results  suggest  that  the  Th response 
i s  s k e w e d  t o w a r d  t h e  T h 1  p r o f i l e  i n  o u r  D S S  m o d e l .  
However, supplemental experiments examining mRNA levels 
of the cytokine genes IFN-γ, IL-4 and IL-17 by real-time PCR 
would  provide  a  further  validation  for  our  conclusion. 
Similarly, examining expression levels of the Th cell promot-
ing transcription factors T-bet (Th1), GATA-3 (Th2) and ROR-
γ  (Th17)  from  lamina  propria  CD3
＋CD4
＋  sorted  cells 
should provide a more comprehensive and definitive answer. 
In  conclusion,  we  provide  evidence  suggesting  that  in  the 
murine model of acute DSS-colitis the colonic T cells are po-
l a r i z e d  t o  a  T h 1  p r o f i l e  a n d  n o t  a  T h 1 7  p r o f i l e .
ACKNOWLEDGEMENTS
This  work  was  supported  in  part  by  the  New  Investigator 
Fund  from  Yonsei  University  at  Wonju  (#2011-5-5018).
CONFLICTS OF INTEREST
The  authors  have  no  financial  conflict  of  interest.
REFERENCES
1. Xavier RJ, Podolsky DK: Unravelling the pathogenesis of in-
flammatory  bowel  disease.  Nature  448;427-434,  2007.
2. Strober W, Fuss I, Mannon P: The fundamental basis of in-
flammatory bowel disease. J Clin Invest 117;514-521, 2007.
3. Strober W: Why study animal models of IBD? Inflamm Bowel 
Dis  14(Suppl  2);S129-S131,  2008.
4. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, 
Nakaya R: A novel method in the induction of reliable ex-
perimental  acute  and  chronic  ulcerative  colitis  in  mice. 
Gastroenterology  98;694-702,  1990.
5. Pizarro TT, Cominelli F: Cytokine therapy for Crohn's disease: 
advances in translational research. Annu Rev Med 58;433-444, 
2007.
6. Fuss  IJ,  Becker  C,  Yang Z, Groden  C, Hornung  RL,  Heller 
F , N e u r a th  M F , S tr o b e r W , M a n n o n  P J : B o th  I L - 1 2 p 7 0  a n d 
IL-23 are synthesized during active Crohn's disease and are 
down-regulated by treatment with anti-IL-12 p40 monoclonal 
antibody.  Inflamm  Bowel  Dis  12;9-15,  2006.
7. Alex P, Zachos NC, Nguyen T, Gonzales L, Chen TE, Conklin 
LS, Centola M, Li X: Distinct cytokine patterns identified from 
multiplex profiles of murine DSS and TNBS-induced colitis. 
Inflamm  Bowel  Dis  15;341-352,  2009.
8. Wu S, Rhee KJ, Albesiano E, Rabizadeh S, Wu X, Yen HR, 
H u s o  D L ,  B r a n c a t i  F L ,  W i c k  E ,  M c A l l i s t e r  F ,  H o u s s e a u  F ,  
Pardoll DM, Sears CL: A human colonic commensal promotes 
colon tumorigenesis via activation of T helper type 17 T cell 
responses.  Nat  Med  15;1016-1022,  2009.
9. Brown JB, Cheresh P, Zhang Z, Ryu H, Managlia E, Barrett 
TA: P-selectin glycoprotein ligand-1 is needed for sequential 
recruitment of T-helper 1 (Th1) and local generation of Th17 
T cells in dextran sodium sulfate (DSS) colitis. Inflamm Bowel 
Dis  2011.  [Epub  ahead  of  print]
10. Sanada Y, Mizushima T, Kai Y, Nishimura J, Hagiya H, Kurata 
H, Mizuno H, Uejima E, Ito T: Therapeutic effects of novel 
sphingosine-1-phosphate  receptor  agonist  W-061  in  murine 
DSS  colitis.  PLoS  One  6;e23933,  2011.
11. Nuñez-Andrade  N,  Lamana  A,  Sancho  D,  Gisbert  JP, 
Gonzalez-Amaro R, Sanchez-Madrid F, Urzainqui A: P-selectin 
glycoprotein  ligand-1  modulates  immune  inflammatory  re-
sponses in the enteric lamina propria. J Pathol 224;212-221, 
2011. 
12. Ito  R,  Kita  M,  Shin-Ya  M,  Kishida  T,  Urano  A,  Takada  R, 
Sakagami J, Imanishi J, Iwakura Y, Okanoue T, Yoshikawa 
T, Kataoka K, Mazda O: Involvement of IL-17A in the patho-
genesis of DSS-induced colitis in mice. Biochem Biophys Res 
Commun  377;12-16,  2008.
13. Egger B, Bajaj-Elliott M , M acD onald TT, Inglin R, Eysselein 
VE, Büchler MW: Characterisation of acute murine dextran so-
dium sulphate colitis: cytokine profile and dose dependency. 
Digestion  62;240-248,  2000.T Helper Cell Responses in DSS Colitis Model
Yoon Suk Kim, et al.
419 IMMUNE NETWORK http://www.ksimm.or.kr Volume 11 Number 6 December 2011
14. Nam JS, Terabe M, Kang MJ, Chae H, Voong N, Yang YA, 
Laurence A, Michalowska A, Mamura M, Lonning S, Berzofsky 
JA, Wakefield LM: Transforming growth factor beta subverts 
the  immune  system  into  directly  promoting  tumor  growth 
through  interleukin-17.  Cancer  Res  68;3915-3923,  2008.
15. Pichavant  M,  Goya  S,  Meyer  EH,  Johnston  RA,  Kim  HY, 
Matangkasombut P, Zhu M, Iwakura Y, Savage PB, DeKruyff 
RH, Shore SA, Umetsu DT: Ozone exposure in a mouse mod-
el induces airway hyperreactivity that requires the presence 
o f natural k iller T  ce lls an d IL-17. J E x p  M ed 20 5;38 5-39 3, 
2008.
16. Rachitskaya AV, Hansen AM, Horai R, Li Z, Villasmil R, Luger 
D, Nussenblatt RB, Caspi RR: Cutting edge: NKT cells con-
stitutively express IL-23 receptor and RORgammat and rapidly 
produce IL-17 upon receptor ligation in an IL-6-independent 
fashion.  J  Immunol  180;5167-5171,  2008.
17. Ferretti S, Bonneau O, Dubois GR, Jones CE, Trifilieff A: IL-17, 
produced by lymphocytes and neutrophils, is necessary for 
lipopolysaccharide-induced  airway  neutrophilia:  IL-15  as  a 
possible  trigger.  J  Immunol  170;2106-2112,  2003.
18. Takahashi N, Vanlaere I, de Rycke R, Cauwels A, Joosten LA, 
Lubberts E, van den Berg WB, Libert C: IL-17 produced by 
Paneth cells drives TNF-induced shock. J Exp Med 205;1755- 
1761,  2008.
19. Duan J, Chung H, Troy E, Kasper DL: Microbial colonization 
drives expansion of IL-1 receptor 1-expressing and IL-17-pro-
ducing  gamma/delta  T  cells.  Cell  Host  Microbe  7;140-150, 
2010.